Alchemab Therapeutics
StartupBiotech & Life SciencesDeep TechBritish
Alchemab Therapeutics is a clinical-stage biotech company that discovers antibody therapeutics by analysing the immune repertoires of individuals naturally resilient to diseases such as ALS, Huntington's and cancer.
Locations
Funding
£25mSeries A9 Jul
Led by British Business Bank